Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    13007
Show Display Options
Rank Status Study
1 Completed
Has Results
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: vedolizumab;   Other: Placebo
2 Not yet recruiting Genetic Autopsy and Sudden Death
Condition: Sudden Death
Intervention: Genetic: Heart and spleen tissue
3 Completed Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia
Condition: Essential Thrombocythaemia
Interventions: Drug: Anagrelide retard;   Drug: Placebo
4 Completed Sole Local Anesthetic Versus Opioid Plus Local Anesthesia in Epidural Labor Analgesia
Condition: Pain
Interventions: Drug: Sole local anesthetic;   Drug: Sufentanil (Opioid plus local anesthetic);   Drug: Ropivacaine
5 Recruiting Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)
Condition: Rheumatoid Arthritis
Interventions: Drug: Bredinin tablet 150mg;   Drug: Bredinin tablet 50mg
6 Completed A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.
Condition: Acute Myocardial Infarction
Interventions: Biological: CSL112;   Biological: Placebo
7 Recruiting GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)
Conditions: Stroke;   Atrial Fibrillation
Intervention:

Study has passed its completion date and status has not been verified in more than two years.